Inside America’s Opioid Crisis: A Book Event

Why It Matters

The recommendations could halve overdose deaths and save billions by aligning funding with evidence‑based, community‑driven treatment, reshaping national drug policy for the next generation.

Key Takeaways

• Overdose deaths fell 26% in 2023, reversing two decades.
• Only ~25% of people with SUD receive treatment currently.
• Author proposes $10 billion annual increase to federal drug budget.
• Emphasizes hiring 100,000 recovery coaches over ten years.
• Calls for more data on long‑term outcomes of interventions.

Summary

The event, hosted by AEI and featuring former drug‑policy czar Rich Bowden, centered on his new book “Inside the Opioid Crisis: 12 Hard Lessons for Today’s Drug War.” Speakers highlighted a recent 26 percent drop in overdose deaths in 2023—the first national decline in two decades—while warning that the underlying addiction epidemic remains massive.

Bowden traced the crisis from the 1996 launch of OxyContin through the surge of heroin and, most recently, fentanyl‑laden synthetic opioids mixed with cocaine and methamphetamine. He noted that roughly 10 million Americans now misuse this dangerous cocktail, and that only about a quarter of those with a substance‑use disorder receive treatment. Federal drug‑control spending sits near $46 billion, yet the economic toll of the epidemic exceeds $1 trillion annually.

Key recommendations from the book include a $10 billion annual boost to the federal drug budget, the creation of 1,000 walk‑in engagement centers, and hiring 100,000 recovery coaches over ten years—costing roughly $1 billion per year. Bowden stressed the need for robust data on long‑term outcomes and a stronger role for NGOs to monitor and refine interventions such as drug courts and syringe‑exchange programs.

If policymakers adopt these proposals, the United States could shift from a reactive, supply‑focused approach to a prevention‑oriented model that expands treatment access, improves accountability, and ultimately reduces the human and fiscal costs of the opioid epidemic.

Original Description

Why are the country’s efforts to reduce addiction and drug-related crime not working? Will the declining trend in overdose fatalities continue? In his comprehensive new book, Inside America’s Opioid Crisis: 12 Hard Lessons for Today’s Drug War, Richard J. Baum, former acting director of the Office of National Drug Control Policy, argues that the United States is confronting a synthetic drug epidemic with systems designed for an earlier era of heroin and prescription opioids.

In this AEI event, a panel of respondents—including a criminologist, a health policy analyst, and a historian—will offer observations on the book’s account of the forces that have driven our latest drug epidemic and discuss recommendations on preparing policymakers for future drug threats.

Subscribe to AEI's YouTube Channel

https://www.youtube.com/user/AEIVideos?sub_confirmation=1

Like us on Facebook

https://www.facebook.com/AEIonline

Follow us on Twitter

https://twitter.com/AEI

For more information

http://www.aei.org

AEI operates independently of any political party and does not take institutional positions on any issues. AEI scholars, fellows, and their guests frequently take positions on policy and other issues. When they do, they speak for themselves and not for AEI or its trustees or other scholars or employees.

More information on AEI research integrity can be found here: http://www.aei.org/about/

#aei #news #politics #government #education #livestream #live #opioidcrisis #addiction #medicine